Methods of treating cutaneous lupus erythematosus and systemic lupus erythematosus
MYPI2026002918A0Undetermined Publication Date: 2022-06-03BIOGEN MA INC
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- MYPI2026002918
- Authority / Receiving Office
- MY · MY
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2020-12-03
- Filing Date
- 2021-12-03
- Publication Date
- 2022-06-03
Abstract
Dosage regimens of anti-Blood Dendritic Cell Antigen 2 antibodies are provided for use in the treatment of cutaneous lupus erythematosus and systemic lupus erythematosus. Figure 1.
Need to check novelty before this filing date? Find Prior Art
